✦ LIBER ✦

Results of surgical treatment of hepatocellular carcinoma in patients with metabolic syndrome as unique oncological risk factor

✍ Scribed by Ajani, C.; Magra, E.; David, E.; Paraluppi, G.; Saffioti, M.C.; Colli, F.; Patrono, D.; Romagnoli, R.; Salizzoni, M.

Book ID: 122155692
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 53 KB
Volume: 46
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2014.01.081

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Hypertension and Other Card

Treatment of Hypertension and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome

✍ Suzuki, Takeki; Homma, Shunichi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Radiofrequency Ablation of Hepatocellula

Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis

✍ Lee, Dong Ho; Lee, Jeong Min; Lee, Jae Young; Kim, Se Hyung; Yoon, Jung Hwan; Ki 📂 Article 📅 2014 🏛 The Radiological Society of North America 🌐 English ⚖ 504 KB

Underestimation of the influence of sate

Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma

✍ Aurélie Plessier; Liana Codes; Yann Consigny; Daniele Sommacale; Federica Donder 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

Liver transplantation offers good results in patients with small hepatocellular carcinoma. However, 3 to 15% of patients still have recurrence, suggesting that factors other than the size and number of nodules are implicated. The aim of our study was to identify predictive factors of recurrence in p

Quality of life as a prognostic factor o

Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials

✍ Franck Bonnetain; Xavier Paoletti; Sandra Collette; Michel Doffoel; Olivia Bouch 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 252 KB

447 Evaluation of percutaneous ablation

447 Evaluation of percutaneous ablation treatments of hepatocellular carcinoma (HCC) as a risk factor for neoplastic recurrence in patients who underwent liver transplant (LT)

✍ V.G. Mirante; M. Pompili; G. Rondinara; D. Forti; G. Rossi; L.R. Fassati; S. Agn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Effect of Metabolic Syndrome Factors and

Effect of Metabolic Syndrome Factors and Insulin Resistance on Ezetimibe/Simvastatin and Atorvastatin Treatment Efficacy in Patients with Metabolic Syndrome and Moderately High/High CHD Risk

✍ Jeffrey B. Rosen; Christie M. Ballantyne; Scott M. Grundy; Willa A. Hsueh; Hans- 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 264 KB